JP2011506294A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506294A5
JP2011506294A5 JP2010536469A JP2010536469A JP2011506294A5 JP 2011506294 A5 JP2011506294 A5 JP 2011506294A5 JP 2010536469 A JP2010536469 A JP 2010536469A JP 2010536469 A JP2010536469 A JP 2010536469A JP 2011506294 A5 JP2011506294 A5 JP 2011506294A5
Authority
JP
Japan
Prior art keywords
carboxylate
methyl
piperazine
morpholin
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010536469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506294A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/066877 external-priority patent/WO2009071658A1/en
Publication of JP2011506294A publication Critical patent/JP2011506294A/ja
Publication of JP2011506294A5 publication Critical patent/JP2011506294A5/ja
Pending legal-status Critical Current

Links

JP2010536469A 2007-12-05 2008-12-05 抗肥満薬としてのピペラジン Pending JP2011506294A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0702696 2007-12-05
US2298308P 2008-01-23 2008-01-23
PCT/EP2008/066877 WO2009071658A1 (en) 2007-12-05 2008-12-05 Piperazines as anti-obesity agents

Publications (2)

Publication Number Publication Date
JP2011506294A JP2011506294A (ja) 2011-03-03
JP2011506294A5 true JP2011506294A5 (cg-RX-API-DMAC7.html) 2013-02-07

Family

ID=40409928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010536469A Pending JP2011506294A (ja) 2007-12-05 2008-12-05 抗肥満薬としてのピペラジン

Country Status (17)

Country Link
US (3) US20110059969A1 (cg-RX-API-DMAC7.html)
EP (1) EP2229362A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011506294A (cg-RX-API-DMAC7.html)
KR (1) KR20100093104A (cg-RX-API-DMAC7.html)
CN (1) CN102026975A (cg-RX-API-DMAC7.html)
AU (1) AU2008333173A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0819989A2 (cg-RX-API-DMAC7.html)
CA (1) CA2707555A1 (cg-RX-API-DMAC7.html)
CO (1) CO6280487A2 (cg-RX-API-DMAC7.html)
CR (1) CR11479A (cg-RX-API-DMAC7.html)
DO (1) DOP2010000167A (cg-RX-API-DMAC7.html)
EA (1) EA201000926A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010234A (cg-RX-API-DMAC7.html)
IL (1) IL205874A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010006259A (cg-RX-API-DMAC7.html)
WO (1) WO2009071658A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003976B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093248B2 (en) * 2007-12-05 2012-01-10 Astrazeneca Ab (Publ) Compounds useful for the treatment of conditions associated with weight gain
KR20100097701A (ko) * 2007-12-05 2010-09-03 아스트라제네카 아베 비만 치료제로서의 모르폴린 유도체
KR101810975B1 (ko) * 2010-07-08 2017-12-20 에스케이바이오팜 주식회사 카바모일옥시 아릴알칸노일 아릴피페라진계 화합물을 포함하는 약학적 조성물
US20140005188A1 (en) 2011-03-11 2014-01-02 Glaxo Group Limited Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
US11807622B2 (en) 2019-01-30 2023-11-07 Insilico Medicine Ip Limited TLR 9 inhibitors
US10689360B1 (en) * 2019-01-30 2020-06-23 Insilico Medicine Ip Limited TLR inhibitors
CN113149891B (zh) * 2020-01-07 2024-02-02 南京药石科技股份有限公司 一种2-氨基-2-(1-甲基-4-哌啶基)乙醇的制备方法
CN117777048B (zh) * 2023-09-25 2024-09-20 上海科利生物医药有限公司 一种手性2-羟甲基吗啉-4-羧酸叔丁酯的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
BR9709529A (pt) 1996-06-06 1999-08-10 Smithkline Beecham P L C Socie Fragmentos de leptina (proteína ob)
US6057337A (en) * 1998-02-02 2000-05-02 Shiseido Co., Ltd. 1,2-DI-substituted piperidine derivative, hair growth promoter and external composition for skin using the same
JP2001131149A (ja) 1999-11-08 2001-05-15 Sumitomo Pharmaceut Co Ltd 選択的セロトニン再取り込み阻害剤
JP2001261657A (ja) 2000-03-17 2001-09-26 Yamanouchi Pharmaceut Co Ltd シアノフェニル誘導体
IL155092A0 (en) 2000-09-29 2003-10-31 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases
ES2197003B1 (es) * 2002-04-08 2005-03-16 J. URIACH & CIA S.A. Nuevos compuestos antagonistas de integrinas alfa.
MXPA05013365A (es) 2003-06-20 2006-04-05 Arena Pharm Inc Derivados de n-fenil-piperazina y metodos para profilaxis o tratamiento de enfermedades asociadas con el receptor 5ht2c.
US7700597B2 (en) * 2004-12-03 2010-04-20 Schering Corporation Substituted piperazines as CB1 antagonists
DE102005000666B3 (de) 2005-01-04 2006-10-05 Sanofi-Aventis Deutschland Gmbh Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20090325975A1 (en) 2005-07-15 2009-12-31 Helmut H Buschmann Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
EP1787679A1 (en) 2005-07-29 2007-05-23 Laboratorios Del Dr. Esteve, S.A. Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
US7790726B2 (en) 2005-08-16 2010-09-07 Chemocentryx, Inc. Monocyclic and bicyclic compounds and methods of use
EP1991211A1 (en) 2006-02-28 2008-11-19 Laboratorios Del Dr. Esteve, S.A. Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
KR20100097701A (ko) 2007-12-05 2010-09-03 아스트라제네카 아베 비만 치료제로서의 모르폴린 유도체
KR20100097725A (ko) 2007-12-05 2010-09-03 아스트라제네카 아베 신규 화합물 ⅲ
US8093248B2 (en) 2007-12-05 2012-01-10 Astrazeneca Ab (Publ) Compounds useful for the treatment of conditions associated with weight gain
JP2011522009A (ja) 2008-06-04 2011-07-28 アストラゼネカ アクチボラグ 新規化合物vii
JP2011522006A (ja) 2008-06-04 2011-07-28 アストラゼネカ アクチボラグ 新規化合物v
AU2009254557A1 (en) 2008-06-04 2009-12-10 Astrazeneca Ab (Publ) Small molecule leptin receptor modulators
MX2010013359A (es) 2008-06-04 2011-04-07 Astrazeneca Ab Nuevos derivados de piridina como mimeticos moduladores del receptor de leptina.

Similar Documents

Publication Publication Date Title
ES2752039T3 (es) Agente terapéutico para la dislipidemia
CN1582278A (zh) 多晶型rimonabant,其制备方法及含有它的药物组合物
JP2010510999A5 (cg-RX-API-DMAC7.html)
JP2011528658A5 (cg-RX-API-DMAC7.html)
JP2010516702A5 (cg-RX-API-DMAC7.html)
JP2008520742A5 (cg-RX-API-DMAC7.html)
CN1610680A (zh) 莨菪品酯的制备方法
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2007510662A5 (cg-RX-API-DMAC7.html)
JP2013532668A5 (cg-RX-API-DMAC7.html)
JP2011516498A5 (cg-RX-API-DMAC7.html)
JP2011523952A5 (cg-RX-API-DMAC7.html)
TW202200594A (zh) 一種glp-1受體激動劑的晶型a及其製備方法
JP2010522710A5 (cg-RX-API-DMAC7.html)
JP2004307440A (ja) 2−アミノ‐1,3‐プロパンジオール誘導体とその付加塩
CN1352640A (zh) 氨氯地平和阿托伐他汀的共同前体药物
CN103562190A (zh) 作为抗寄生虫药的异噁唑啉衍生物
JP2005502636A5 (cg-RX-API-DMAC7.html)
ES2642172T3 (es) Compuestos derivados de ciclohexeno sustituidos con biarilo o biarilo heterocíclico como inhibidores de CETP
EP3432881A1 (en) Use of ddx3 inhibitors as antiproliferative agents
CN1166623C (zh) 2-苯氧基苯胺类衍生物
JP2009502770A5 (cg-RX-API-DMAC7.html)
CN1119183A (zh) 邻氨基取代的苯甲酰胍、其制备方法、药用以及药品
CN1241921C (zh) 含氟异黄酮衍生物、制造方法及其用途
CA2798374A1 (en) Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases